HK Globle Sino Ocean Dev. Co., Limited

 

Guaranteed Quality Of Raw Steroids Powder & Pre-Mix Liquid, Fast Shipment, Best Service!

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsAnti Estrogen Steroids

Fulvestrant Powder Antiandrogen Drug 99% Purity For Female CAS 129453-61-8

Good quality Bodybuilding Anabolic Steroids for sales
wow you did this like super pros I mean wow ...gotta hand it to you I am impressed and I thought I was sneaky. absolutely SUPER PROFESSIONAL!!!

—— Chris

Everything is fantastic! You have the best packaging and fast shipping!Provided powder is very good,i'm very pleased to work with you!

—— Jaroslaw

Your Semi-finished product is very good! Best concentration and color. next week i will send email to you about my new order!

—— Manny

we were able to check it out and were pleased with our results/feedback. We are shooting to place another order shortly. We will contact you as soon!

—— Andrew

I'm Online Chat Now

Fulvestrant Powder Antiandrogen Drug 99% Purity For Female CAS 129453-61-8

China Fulvestrant Powder Antiandrogen Drug 99% Purity For Female CAS 129453-61-8 supplier

Large Image :  Fulvestrant Powder Antiandrogen Drug 99% Purity For Female CAS 129453-61-8

Product Details:

Place of Origin: China
Brand Name: Anti Estrogen Steroids
Certification: GMP, ISO, KOSHER
Model Number: CAS:129453-61-8

Payment & Shipping Terms:

Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: according your quantity to choice different package
Delivery Time: send the package within 24 hours after payment
Payment Terms: Western Union, MoneyGram, T/T, Bitcoin
Supply Ability: 200kg/week
Contact Now
Detailed Product Description
Other Name: Fulvestrant Assay: 99.5%
Molecular Formula: C32H47F5O3S Molecular Weight: 606.77
Character: White Power Grade Standard: Medicine Grade
Storage: Cool, Ventilated And Dry Place Suitable For: Adult, Bodybuilder
High Light:

Low Estrogen Steroids

,

Pharma Grade Steroids

Fulvestrant Powder Antiandrogen Drug 99% Purity For Female CAS 129453-61-8​

 

 

Quick Detail:

CAS: 129453-61-8
Purity: 99%
Appearance:white powder
Synonyms: FASLODEX
Chemical Name: (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol
Molecular Fomular: C32H47F5O3S
Molecular Weight: 606.77
Density: 1.201 g/cm3
Melting Point: 104-106°C
Boiling Point: 674.8 °C at 760 mmHg
Package:10g/foil bag
Usage: Antineoplastic (hormonal)

 

Description:

In particular 4 clinical trials in this setting did show similar efficacy to the other hormonal agents (aromatase inhibitors and tamoxifen) with good tolerability profile. Fulvestrant had a lower incidence of joint disorders.

 

Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.

 

Applications:

Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.


Fulvestrant (Faslodex, AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.


Fulvestrant is a selective estrogen receptor down-regulator (SERD). Fulvestrant is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for fulvestrant remains under investigation in an attempt to optimize its effectiveness.

 

Contact Details
HK Globle Sino Ocean Dev. Co., Limited

Contact Person: Crystal

Send your inquiry directly to us (0 / 3000)